https://www.selleckchem.com/products/mrtx0902.html
0.0001) from 2003 through 2015; however, the estimated treatment rate for UCAs was only 0.19 (95% CI 0.19-0.2 to 0.51 (95% CI 0.50-0.51) among all UCA patients. The prevalence of hypertension (males, p = 0.0003; females, p less then 0.0001) and current smoking status (males, p less then 0.0001; females, p = 0.0002) declined significantly from 2003 through 2015, while the use of cholesterol-lowering drugs increased significantly (males, p less then 0.0001; females, p = 0.0005) during the same period. CONCLUSIONS The estimated nationwi